Title f-27 LAWS reference
Explore the full hierarchy of this title across chapters, subchapters, and parts.
Select a part from the tree to begin
Browse chapters and parts on the left to load sections
Title f-27 Laws — Food and Drugs Act
Browse the 140 parts that make up Title f-27 of the CANADA Laws. Each part covers a distinct regulatory area; expand any part to view its full text.
- Part SCHEDULE A.1SCHEDULE A.1
- Part 1Short title
- Part 2Definitions
- Part 2.1Non-corrective contact lenses
- Part 2.2Tobacco products
- Part 2.3Vaping products
- Part 2.4Classification — thing
- Part 3Prohibited advertising
- Part 3.1Prohibition — clinical trials
- Part 3.2Terms and conditions — clinical trial authorizations
- Part 3.3Duty to publicize clinical trial information
- Part 4Deeming provision
- Part 4Prohibited sales of food
- Part 5Pest control products
- Part 5Deception, etc., regarding food
- Part 6Importation and interprovincial movement of food
- Part 6.1Governor in Council may identify standard or portion thereof
- Part 7Unsanitary manufacture, etc., of food
- Part 8Prohibited sales of drugs
- Part 9Deception, etc., regarding drugs
- Part 10Where standard prescribed for drug
- Part 11Unsanitary manufacture, etc., of drug
- Part 11.1Risk to environment
- Part 12Drugs not to be sold unless safe manufacture indicated
- Part 13Therapeutic product authorizations
- Part 13Drugs not to be sold unless safe batch indicated
- Part 14Samples
- Part 15Schedule F drugs not to be sold
- Part 16Prohibited sales of cosmetics
- Part 16.1Prohibited sales — animal testing
- Part 16.2Prohibition — animal testing
- Part 16.3Prohibited claims — animal testing
- Part 17Where standard prescribed for cosmetic
- Part 18Unsanitary conditions
- Part 19Prohibited sales of devices
- Part 20Deception, etc., regarding devices
- Part 21Where standard prescribed for device
- Part 21.1Power to require information — serious risk
- Part 21.2Modification or replacement — labelling or packaging
- Part 21.3Minister’s powers — risk of injury to health
- Part 21.301Information — serious environmental risk
- Part 21.302Labelling or packaging — serious risk to environment
- Part 21.303Minister’s powers — serious risk to environment
- Part 21.31Power to require assessment
- Part 21.32Power to require tests, studies, etc.
- Part 21.321Definition of
- Part 21.33Power — information relating to environmental effects
- Part 21.4Availability of orders
- Part 21.5Injunction
- Part 21.6False or misleading information — therapeutic products
- Part 21.7Terms and conditions of authorizations
- Part 21.71Duty to publicize clinical trial information
- Part 21.8Health care institutions to provide information
- Part 21.9Prohibited activities
- Part 21.91Additions to Schedule G
- Part 21.92Advanced therapeutic product licence
- Part 21.93Suspension and revocation
- Part 21.94Exemption
- Part 21.95Order — advanced therapeutic products
- Part 21.96Exemption
Regulatory Context
This document sits within CANADA Laws and is most useful when linked to operational submission, quality, and inspection workflows.
CANADALaws